Predictive Oncology earnings were -$9.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest POAI earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.1M, down 15.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, POAI reported annual earnings of -$12.7M, with -9.4% growth.
Predictive Oncology Earnings Reports & History FAQ
What were Predictive Oncology's earnings last quarter?
Predictive Oncology (NASDAQ: POAI) reported Q2 2025 earnings per share (EPS) of -$0.23, up 66.18% year over year. Total POAI earnings for the quarter were -$2.07 million. In the same quarter last year, Predictive Oncology's earnings per share (EPS) was -$0.68.
Is Predictive Oncology profitable or losing money?
As of the last Predictive Oncology earnings report, Predictive Oncology is currently losing money. Predictive Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$9.78 million, a 30.35% decrease year over year.
What was POAI's earnings growth in the past year?
As of Predictive Oncology's earnings date in Q3 2025, Predictive Oncology's earnings has grown year over year. POAI earnings in the past year totalled -$9.78 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.